LC–MS Deconstructs the "Poppy Seed Defense" - - Chromatography Online
LC–MS Deconstructs the "Poppy Seed Defense"


The Column
Volume 10, Issue 4, pp. 9

Scientists at King’s College London in London, UK, have discovered a new metabolite in urine that is an indicator of heroin (3,6-diacetylmorphine) intake. The paper published in Drug Testing and Analysis suggests that the marker can be used to rule out poppy seed ingestion and confirm illicit drug intake. Heroin is formed by the reaction of morphine in opium with acetic anhydride, and in the body it is metabolized to the primary metabolite 6-monoacetylmorphine (6-MAM). This can be used as a marker of heroin intake, but only has a half-life of only 10–40 min in plasma and can only be detected in urine for 2–8 h after intake. After this time period, analysts are dependent on the presence of morphine in urine, which is a big problem for analysts as many other legal substances, such as poppy seeds, can give the same positive result.

Corresponding author Andrew Kicman, a forensic toxicologist at King’s College London, recalled a dispute from over 10 years ago between two medicinal chemists about the stability of the amide bond. Because acetic anhydride is a general reagent, it reacts nonspecifically with a number of compounds, generating other metabolites that are not found in everyday sources. The team therefore hypothesized that other opiates in heroin could become acetylated on their nitrogen atoms to form stable derivatives. According to Kicman, the isolation of acetylated compounds was challenging, as even semi-preparative chromatography involved hundreds of injections, performed by his student, Pei-Shan Chen. Furthermore: “After isolating one set of compounds, we discovered that the glass tubes we were using for collection were contaminated with detergent from a laboratory washing machine that had developed a fault, so we had to start all over again!”

Liquid chromatography (LC), nuclear magnetic resonance (NMR) spectroscopy, and mass spectroscopy (MS) were performed to identify and characterize the derivatives. However, achieving the necessary sensitivity was difficult. The team initially used nanospray technology but then a year later switched back to a conventional LC–MS approach. Kicman said: “This is the sort of thing you don’t read about in scientific papers, but is all part of the rollercoaster that all researchers face at one time or other.” ATM4G, a glucoronide metabolite, was selected by the team as a potential marker of heroin intake that could only be formed in the presence of acetyl anhydride. To confirm the marker, LC–MS–MS analysis was performed on urine samples collected from 22 known heroin users that had been identified as positive for morphine in gas chromatography–mass spectrometry (GC–MS) analysis but negative for 6-MAM. The proposed marker ATM4G was detected in 16 of the 22 samples.

Andrew Kicman told The Column: “The project was a high risk one, as there was no plan B, but in the end it worked out and we are all very pleased that Pei-Shan Chen received her doctorate and that we have a publication to show for all our efforts, which hopefully others will find useful. We also involved other scientists with various expertise (Peter Hylands, Mark Parkin, Norman Smith), so it was really a superb team effort.”— B.D.

Reference

P. Chen, R.A. Braithwaite, C. George, P.J. Hylands, M.C. Parkin, N.W. Smith, and A.T. Kicman, Drug Test. and Analysis DOI 10.1002/dta.1590 (2013).

This story originally appeared in The Column. Click here to view that issue.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters
Global E-newsletters subscribe here:




 

LCGC COLUMNISTS 2014

Column Watch: Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments. LATEST: When Bad Things Happen to Good Food: Applications of HPLC to Detect Food Adulteration


Perspectives in Modern HPLC: Michael W. Dong is a senior scientist in Small Molecule Drug Discovery at Genentech in South San Francisco, California. He is responsible for new technologies, automation, and supporting late-stage research projects in small molecule analytical chemistry and QC of small molecule pharmaceutical sciences. LATEST: HPLC for Characterization and Quality Control of Therapeutic Monoclonal Antibodies


MS — The Practical Art: Kate Yu brings her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers. LATEST: Radical Mass Spectrometry as a New Frontier for Bioanalysis


LC Troubleshooting: LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan is able to highlight common problems and provide remedies for them. LATEST: How Much Can I Inject? Part I: Injecting in Mobile Phase


More LCGC Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>


Source: The Column,
Click here